Peripheral Artery Disease (PAD)

This channel includes news, interventions, and new technology innovations for peripheral artery diease, PAD and critical limb ischemia.

The FDA cleared the IN.PACT AV drug-coated Balloon. Clinical data shows In.Pact AV DCB is Safe, reduces reinterventions and maintains access for end-stage renal disease patients undergoing dialysis

News

FDA Clears Medtronic Drug-Coated Balloon to Treat Arteriovenous Fistula Lesions

November 21, 2019 — The U.S. Food and Drug Administration (FDA) has cleared the Medtronic In.Pact AV drug-coated balloon ...

November 26, 2019

News | Peripheral Artery Disease (PAD)

The ULYSSE Registry Shows Benefit of Ultrasoundplasty Before Below-the-knee Interventions

November 7, 2019 — Ultrasoundplasty before angioplasty for below-the-knee lesions (BTK) lesions may improve clinical ...

November 14, 2019

News | Peripheral Artery Disease (PAD)

Adventitial Temsirolimus Injections in BTK Lesions Improved Outcomes in TANGO Trial

November 14, 2019 — There were positive results in the TANGO Trial is a phase 2, dose escalation, double-blinded trial ...

November 14, 2019

The LimFlow procedure permanently bypasses unreconstructable arteries and leverages healthier veins as a conduit to create new routes to perfuse tissue in the foot. #VIVA #VIVA19 #VIVA2019

News | Peripheral Artery Disease (PAD)

LimFlow Procedure Successful in Bypassing Unreconstructable Arteries in Limb-threatening Ischemia

November 14, 2019 — Results were positive for the multicenter PROMISE I Trial represents the first human use in the ...

November 14, 2019

The IN.PACT Arteriovenous (AV) Access randomized trial evaluating the safety and effectiveness of the Medtronic IN.PACT AV Access drug-coated balloon (DCB) met both of its endpoints, in data presented at the 2019 Vascular Interventional Advances (VIVA) annual meeting. #VIVA #VIVA19 #VIVA2019

News | Drug-Eluting Balloons

IN.PACT AV Access 6-Month Data Show Increased Vessel Patency

November 7, 2019 — The IN.PACT Arteriovenous (AV) Access randomized trial evaluating the safety and effectiveness of the ...

November 14, 2019

The Rex Medical Revolution rotational atherectomy system incorporates continuous aspiration and has a dual indication for atherectomy and thrombectomy. #VICA19 #VIVA2019

News | Atherectomy Devices

Revolution Rotational Atherectomy System Effective in IDE Experience

November 7, 2019 — The REVEAL FDA investigational device exemption (IDE) trial confirmed a favorable safety and ...

November 11, 2019

The repuncturable Supera vascular mimetic peripheral stent system from Abbott Vascular was shown to manage bulky, heavily calcified CFA disease due to its extreme crush resistance in the VMI-CFA study. #VIVA #VIVA19 #VIVA2019

News | Stents Carotid

Supera Safe to use for Femoral Stenting Versus Surgery in VMI-CFA Trial

November 11, 2019 — Although common femoral artery (CFA) endarterectomy is still considered the gold standard treatment ...

November 11, 2019

News

One-Year Results of the DISAPEAR Registry Positive for Absorb Stent

November 8, 2019 — The Absorb bioresorbable stent (BVS) demonstrated good patency and clinical outcomes in patients with ...

November 08, 2019

News | Stents Bioresorbable

Bioresorbable Stent Shows Good 5-Year Outcomes in ABSORB BTK Trial

November 7, 2019 — Although the Abbott Absorb fully bioresorbable drug-eluting stent (DES) was taken off the market due ...

November 07, 2019

In.Pact Admiral drug-coated balloon (DCB). #VIVA #VIVA19 #VIVA2019

News | Drug-Eluting Balloons

Drug-coated Balloon Maintains Good Outcomes in 4-Year IN.PACT Global Study Data

November 7, 2019 — Real-world, four-year study results of the In.Pact Admiral drug-coated balloon (DCB) demonstrate long ...

November 07, 2019

The AngioDynamics/Eximo Medical B-Laser represents a new atherectomy device. #VIVA2019 #VIVA #VIVA19

News | Atherectomy Devices

No Difference Between Drug-coated Balloons and Plain Balloons After Laser Atherectomy

November 7, 2019 — There was no difference between drug-coated balloons (DCB) vs. plain old balloon angioplasty (POBA) ...

November 07, 2019

The final, long-term, patient-level data for the Cook Medical Zilver PTX drug-eluting stent (DES) were evaluated to determine if there is an increased mortality risk due to paclitaxel, but was no difference was seen in the five-year mortality rates compared to control patients. #VIVA19 #VIVA #VIVA2019

Feature | Stents Peripheral | Dave Fornell, Editor

No Increased Long-Term Mortality for the Paclitaxel-Coated Zilver PTX Stent

November 6, 2019 – The final, long-term, patient-level data for the Cook Medical Zilver PTX drug-eluting stent (DES) ...

November 06, 2019

The Selution SLR, MedAlliance’s novel sirolimus-eluting balloon, #VIVA2019 #VIVA #VIVA19

News | Drug-Eluting Balloons

Safety and Efficacy Sustained Over Two Years in Selution Drug-eluting Balloon First-in-Human Trial

November 6, 2019 – Positive, two-year data from the first-in-human study of Selution SLR, MedAlliance’s novel sirolimus ...

November 06, 2019

Eluvia and Ranger PAD devices from Boston Scientific. #VIVA19 #VIVA2019 #VIVA

News | Peripheral Artery Disease (PAD)

Positive Data for the Ranger Drug-coated Balloon and Eluvia Vascular Stent

November 6, 2019 – Boston Scientific announced positive data for two of its devices within the peripheral drug-eluting ...

November 06, 2019

Viva conference late breaking clinical trials, #VIVA19 #VIVA #VIVA2019

Feature | VIVA

VIVA 2019 Late-breaking Clinical Trials

November 14, 2019 — The results of the 21 late-breaking clinical trials presented for the first time at V ascular ...

November 14, 2019